Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: abdominal pain; Painful periods; Headache; Nausea; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106040910078540-IX13B. Safety Report Unique Identifier: GB-MHRA-ADR 25418903. A 33-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 02Jun2021 (Lot Number: EW3143) as single dose for covid-19 immunization. Medical history included suppressed lactation. The patient''s concomitant medications were not reported. The patient experienced abdominal pain on an unspecified date with outcome of recovering, painful periods on 03Jun2021 with outcome of not recovered, headache and nausea on 03Jun2021 with outcome of recovering. Took paracetamol which seemed to have somewhat relieve the headache, but the abdominal pain still persists. Seriousness criteria reported as medical significant. Patient has not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient is not enrolled in clinical trial. Patient is not pregnant, Patient is not currently breastfeeding. Patient has not tested positive for COVID-19 since having the vaccine No follow-up attempts are needed. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166